21st, 2023
S1 “AMEDSCARDA/JST Moonshot”
Florent Ginhoux (Gustave Roussy, Grand Paris, France)
Raul Andino (Microbiology and Immunology, UCSF and Osaka University)
S2 “Neovasccinology”
Bali Pulendran (Stanford University, Institute for Immunology, Transplantation and Infection)
Samuel M. Behar (University of Massachusetts Chan Medical School)
Ken J. Ishii (Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo (IMSUT)/International Vaccine Design Center (vDESC), IMSUT/UTOPIA, U Tokyo)
Trevor Clancy (NEC OncoImmunity, Norway/Institute of Tropical Medicine, Nagasaki University, Japan)
S3 “Mucosal-Immunology”
Jun Kunisawa (Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition)
James Di Santo (Innate Immunity Unit, Inserm U1223, Institut Pasteur, Paris, France)
Keigo Ueno (Department of Fungal Infection, National Institute of Infectious Diseases)
Masaya Yamaguchi (Bioinformatics Research Unit, Osaka University, Graduate School of Density, Japan/Osaka University, Center for Infectious Disease Education and Research, Japan)
S4 “Microbiota-gut-brain-axis”
Kenya Honda (Keio University School of Medicine/RIKEN Center for Integrative Medical Sciences)
Sidonia Fagarasan (Laboratory for Mucosal Immunity, Center for Integrative Medical Sciences, RIKEN Yokohama Institute, Yokohama, Japan/Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto University, Kyoto Japan)
Taich Suzuki (Biodesign Center for Health Through Microbiomes and College of Health Solutions, Arizona State University, USA)
Ayano Fukui (Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)
S5 “Microbial immune escape/resistance”
Yukihiro Akeda (Department of Bacteriology I, National Institute of Infectious Diseases, Japan/Research Institute for Microbial Diseases, Osaka University)
Keiji Kuba (Kyushu University Graduate School of Medical Sciences)
Rayhane Nchioua (Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany)
S6 “Immuno-Parasitology”
Maria Mota (Instituto de Medicina Molecular Joao Lobo Antunes, Portugal)
Cevayir Coban (Institute of Medical Science (IMSUT), the University of Tokyo, Division of Malaria Immunology)
Huai Chuang (Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Japan/Graduate School of Biomedical Sciences, Nagasaki University, Japan)
Jalal Alshaweesh (Institute of Tropical Medicine, Nagasaki University, Japan)
S7 “Emerging infectious diseases”
Onder Ergonul (Koc University School of Medicine)
Anavaj Sakuntabhai (Pasteur International Research Center for Emerging Infectious Diseases (PICREID)/Ecology and Emergence of Arthropod-borne Pathogens unit, Department of Global Hearth, Institut Pasteur, Paris, France/International Vaccine Design Center (vDesC), The Institute of Medical Sciences, The University of Tokyo (IMSUT), Tokyo, Japan)
Yumiko Imai (Project Leader of the Infection Medical Information Laboratory, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN))
Ravindra Kumar Gupta (University of Cambridge)
S8 “Systems-Immuno-Virology”
David L. Robertson (MRC-University of Glasgow Centre for Virus Research, Scotland)
Kei Sato (The Institute of Medical Science, The University of Tokyo, Japan)
Kentaro Uemura (Faculty of Pharmaceutical Sciences, Hokkaido University, Japan/Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd., Japan/Center for Infectious Disease Education and Research, Osaka University, Japan/Research Institute for Microbial Diseases, Osaka University, Japan)
Chikako Ono (Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University, Japan/ Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Japan)
S9 “Clinical-immuno-microbiology”
Melanie Ott (Gladstone Institute of Virology/University of California San Francisco)
Kenji Kabashima (Kyoto University Graduate school of Medicine)
Yuki Masuo (Department of Immunology, Graduate school of Medicine, Kyoto University/Kyoto University Immunomonitoring Center, Kyoto University, Kyoto, Japan)
David G. Priest (Laboratory of Human Single Cell Immunology, iFReC, Osaka University)
S10 “Interdisciplinary Immunology”
Osamu Nureki (Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan)
Daron M. Standley (Research Institute for Microbial Diseases, Osaka University/Immunology Frontier Research Center, Osaka University, Japan)
Masahiro Nakano (Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Japan/ Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University, Japan/CREST, Japan Science and Technology Agency, Japan)
Shiori Oka (Graduate School of Pharmaceutical Sciences, Kyoto University, Japan)
S11 “Immuno-Metabolism”
Noriko Toyama-Sorimachi (The Institute of Medical Science, The University of Tokyo (IMSUT))
Koji Hase (Faculty of Pharmacy, Keio University/International Research and Development Center for Mucosal Vaccines, the Institute of Medical Science, the University of Tokyo (IMSUT))
Benjamin E. Gewurz (Division of Infectious Diseases, Brigham & Women’s Hospital/Department of Microbiology, Harvard Medical School/Harvard Program in Virology/Center for Integrated Solutions to Infectious Diseases, Broad Institute of Harvard and MIT)
Ryo Ozuru (Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University)
Yukihiro Hiramatsu (Department of Molecular Bacteriology, RIMD, Osaka University, Japan)
S12 “SCARDA”
Yoshihiro Kawaoka (University of Tokyo/National Center for Global Health and Medicine/University of Wisconsin-Madison)
Horoshi Kiyono (Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University, Chiba)
Tokiko Watanabe (Research Institute for Microbial Diseases, Osaka University/The Center for Advanced Modality and DDS (CAMaD), Osaka University)
Kouichi Morita (DEJIMA Infectious Disease Research Alliance, Nagasaki University/Vaccine Research and Development Center, Nagasaki University)
Hirofumi Sawa (Hokkaido University, Institute for Vaccine Research and Development: HU-IVReD)
Jerome Kim (International Vaccine Institute)
Adam Hacker (CEPI)
Osamu Kunii (GHIT Fund)
Luncheon Seminar 1
Norio Ohmagari (National Center for Global Health and Medicine, Disease Control and Prevention Center)
Luncheon Seminar 2
Galit Alter (Moderna, Inc)
Evening Seminar
Tadaki Suzuki (National Institute of Infectious Diseases, Department of Pathology)